FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

MedImmune: Vaccine ready to go at month's end

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools
  • Subscribe
  • Email
  • Print
  • Contact Author
  • Reprint

MedImmune, which began clinical trials for its swine flu vaccine last month, says the inhaled vaccine could be ready by the end of September. The AstraZeneca subsidiary is now waiting on the FDA to review its safety data. "There are no red flags there," Dr. Raburn Mallory told Reuters. "We think we can have 5 million doses ready to distribute at the end of September." Once it gets the greenlight, MedImmune says it will begin shipping the nasal spray vaccine to the U.S. government to fulfill its $90 million contract. Article


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about Vaccine   MedImmune   swine flu   H1N1   AstraZeneca   FDA review